PubRank

Rebecca Klisovic

Author PubWeight™ 18.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 2012 2.65
2 Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia. Blood 2012 1.97
3 Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method. Nucleic Acids Res 2007 1.62
4 Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. Blood 2012 1.51
5 Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Leuk Lymphoma 2014 1.42
6 RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia. Blood 2012 1.33
7 Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res 2013 1.30
8 Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. Biol Blood Marrow Transplant 2009 1.29
9 A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels. Pharm Res 2009 1.07
10 Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation. Biol Blood Marrow Transplant 2008 0.91
11 Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells. AAPS J 2010 0.80
12 In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemia. AAPS J 2012 0.80
13 Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. Leuk Lymphoma 2013 0.80
14 Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2006 0.76
15 Enzyme kinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase. Drug Metab Dispos 2008 0.76
16 The Effect of Aromatherapy on Insomnia and Other Common Symptoms Among Patients With Acute Leukemia Oncol Nurs Forum 2017 0.75